| # | Title | Journal | Year | Citations |
|---|
| 1 | Inflammation, Atherosclerosis, and Coronary Artery Disease | New England Journal of Medicine | 2005 | 7,433 |
| 2 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Blood | 2009 | 3,864 |
| 3 | External review and validation of the Swedish national inpatient register | BMC Public Health | 2011 | 3,713 |
| 4 | Dynamics of fat cell turnover in humans | Nature | 2008 | 1,914 |
| 5 | GRADE guidelines 6. Rating the quality of evidence—imprecision | Journal of Clinical Epidemiology | 2011 | 1,907 |
| 6 | A survey of best practices for RNA-seq data analysis | Genome Biology | 2016 | 1,898 |
| 7 | The immune response in atherosclerosis: a double-edged sword | Nature Reviews Immunology | 2006 | 1,890 |
| 8 | Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 | Journal of Allergy and Clinical Immunology | 2004 | 1,836 |
| 9 | Hundreds of variants clustered in genomic loci and biological pathways affect human height | Nature | 2010 | 1,789 |
| 10 | Inflammation in Atherosclerosis | Journal of the American College of Cardiology | 2009 | 1,738 |
| 11 | A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force | Allergy: European Journal of Allergy and Clinical Immunology | 2001 | 1,395 |
| 12 | Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study | Lancet, The | 1999 | 1,367 |
| 13 | The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months | Pharmacoepidemiology and Drug Safety | 2007 | 1,338 |
| 14 | High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes | Journal of Experimental Medicine | 2000 | 1,306 |
| 15 | Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy | JAMA - Journal of the American Medical Association | 2016 | 1,076 |
| 16 | Natural regulatory T cells control the development of atherosclerosis in mice | Nature Medicine | 2006 | 936 |
| 17 | Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines | Atherosclerosis | 1999 | 862 |
| 18 | Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution | Nature Genetics | 2010 | 836 |
| 19 | Multipotent mesenchymal stromal cells and the innate immune system | Nature Reviews Immunology | 2012 | 811 |
| 20 | 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups | Annals of the Rheumatic Diseases | 2017 | 754 |
| 21 | Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero | Science | 2008 | 749 |
| 22 | Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. | Proceedings of the National Academy of Sciences of the United States of America | 1995 | 733 |
| 23 | A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus | Nature Genetics | 2009 | 729 |
| 24 | Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. | Gut | 1996 | 722 |
| 25 | Novel role of PKR in inflammasome activation and HMGB1 release | Nature | 2012 | 672 |
| 26 | The immunology of atherosclerosis | Nature Reviews Nephrology | 2017 | 667 |
| 27 | EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics | Annals of the Rheumatic Diseases | 2008 | 645 |
| 28 | Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective | European Heart Journal | 2015 | 604 |
| 29 | The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation | Atherosclerosis | 2015 | 587 |
| 30 | Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease | Nature Communications | 2018 | 584 |
| 31 | Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture | Nature Genetics | 2013 | 578 |
| 32 | Identification of a Third Human Polyomavirus | Journal of Virology | 2007 | 574 |
| 33 | Genome-wide association identifies multiple ulcerative colitis susceptibility loci | Nature Genetics | 2010 | 572 |
| 34 | Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry | European Journal of Heart Failure | 2017 | 568 |
| 35 | Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities | New England Journal of Medicine | 1990 | 563 |
| 36 | Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man | Lancet, The | 1992 | 553 |
| 37 | Single-cell immune landscape of human atherosclerotic plaques | Nature Medicine | 2019 | 540 |
| 38 | The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) | Heart | 2010 | 537 |
| 39 | Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium | Blood | 2008 | 508 |
| 40 | Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation | Blood | 2008 | 491 |
| 41 | Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy | American Journal of Medicine | 1998 | 481 |
| 42 | Postprandial lipoproteins and progression of coronary atherosclerosis | Atherosclerosis | 1994 | 472 |
| 43 | Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients | Lancet, The | 1996 | 467 |
| 44 | RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages | Scandinavian Journal of Immunology | 2005 | 457 |
| 45 | Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran | New England Journal of Medicine | 2003 | 444 |
| 46 | Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus | Nature Genetics | 2008 | 436 |
| 47 | Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology | European Journal of Heart Failure | 2018 | 434 |
| 48 | Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia | Lancet, The | 1996 | 432 |
| 49 | Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure | Nature Genetics | 2011 | 403 |
| 50 | Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases | 2011 | 394 |
